Drug intelligence / Profile preview

lunasin-enriched soy extract

Development stage
Preclinical
Lead developer
Missouri Plant Science Center
Modality
Peptides, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

Lunasin-enriched soy extract is a dietary supplement derived from soybeans and specifically enriched for the bioactive peptide lunasin. Lunasin is a 43–44 amino acid peptide with an intramolecular disulfide bond, naturally present in soy and some other grains. The extract contains significantly higher concentrations of lunasin compared to standard soy protein isolates[4][9]. Mechanistically, lunasin exhibits antioxidant, anti-inflammatory, hypocholesterolemic (cholesterol-lowering), and anticancer properties. It acts epigenetically by binding to histone H3 and inhibiting its acetylation by PCAF histone acetylase enzyme; this downregulates HMG-CoA reductase expression (the rate-limiting enzyme in cholesterol biosynthesis) and upregulates LDL receptor expression in liver cells[4]. Lunasin also reduces reactive oxygen species (ROS) production and pro-inflammatory cytokines such as interleukin-1β and interleukin-8[1][5][9]. In cancer models, it inhibits cell proliferation via disruption of mitotic spindle formation and modulates integrin-mediated cell adhesion pathways[7][8]. The product is typically administered orally as capsules or powders but can be formulated into various oral dosage forms[3].

Other names
LSElunasin-enriched soybean extractLES
02

Targets

H3/H4 (Histone H3-H4 complex)KAT2B

Beyond the preview

Go deeper on lunasin-enriched soy extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lunasin-enriched soy extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call